High-sensitive troponinT, interleukin-8, and interleukin-6 link with post-surgery risk in infant heart surgery

Acta Anaesthesiol Scand. 2024 Jul;68(6):745-752. doi: 10.1111/aas.14405. Epub 2024 Mar 26.

Abstract

Background: This study focuses on biomarkers in infants after open heart surgery, and examines the association of high-sensitive troponin T (hs-cTnT), interleukin-6 (IL-6), and interleukin-8 (IL-8) with postoperative acute kidney injury (AKI), ventilatory support time and need of vasoactive drugs.

Methods: Secondary exploratory study from a double-blinded clinical randomized trial (Mile-1) on 70 infants undergoing open heart surgery with cardiopulmonary bypass (CPB). In this sub-study, the entire study population was examined without considering the study drugs. The biomarkers' peak concentration (highest concentration at 2 or 6 h post-CPB) were used for statistical analyses.

Results: Peak IL-8, hs-cTnT, and IL-6 occurred at 2 h post-CPB for 96%, 79%, and 63% of the patients, respectively. The odds ratio of developing AKI2-3 for IL-6 > 293 pg/mL was 23.4 (95% CI 5.3;104.0), for IL-8 > 100 pg/mL it was 11.5 (3.0;44.2), and for hs-cTnT >5597 pg/mL it was 6.1 (1.5; 24.5). In more than two third of the patients with the highest peak concentrations of IL-8, IL-6, and hs-cTnT, there was a need for ventilatory support for >24 h and use of vasoactive drugs at 24 h post-CPB, while in less than one third of the patients with the lowest peak concentrations of IL-8 and hs-cTnT such requirements were observed.

Conclusions: The peak biomarker concentrations and CPB-time strongly predicted AKI2-3, with IL-6 and IL-8 emerging as strongest predictors. Furthermore, our findings suggest that measuring hs-cTnT and IL-8 just 2 h post-CPB-weaning may assist in identifying infants suitable for early extubation and highlight those at risk of prolonged ventilation.

Keywords: acute kidney injury; biomarkers; cardiac surgery; congenital heart defects; infants; outcomes assessments; pediatric intensive care unit.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Acute Kidney Injury* / blood
  • Acute Kidney Injury* / etiology
  • Biomarkers* / blood
  • Cardiac Surgical Procedures*
  • Cardiopulmonary Bypass* / adverse effects
  • Double-Blind Method
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Interleukin-6* / blood
  • Interleukin-8* / blood
  • Male
  • Postoperative Complications* / blood
  • Postoperative Complications* / epidemiology
  • Troponin T* / blood

Substances

  • Interleukin-8
  • Interleukin-6
  • Troponin T
  • Biomarkers
  • CXCL8 protein, human